L’utilisation de la Metformine

Partager cet article

Share on facebook
Share on linkedin
Share on twitter
Share on email
Accueil » Base documentaire » L’utilisation de la Metformine
L’utilisation de la metformine est associée à une réduction de la mortalité dans une population diversifiée souffrant de COVID-19 et de diabète, article paru dans Frontiers in Endocrinology


“Background: Coronavirus disease-2019 (COVID-19) is a growing pandemic with an increasing death toll that has been linked to various comorbidities as well as racial disparity. However, the specific characteristics of these at-risk populations are still not known and approaches to lower mortality are lacking.

Methods: We conducted a retrospective electronic health record data analysis of 25,326 subjects tested for COVID-19 between 2/25/20 and 6/22/20 at the University of Alabama at Birmingham Hospital, a tertiary health care center in the racially diverse Southern U.S. The primary outcome was mortality in COVID-19-positive subjects and the association with subject characteristics and comorbidities was analyzed using simple and multiple linear logistic regression. […] ”

Références & liens


À voir également :

Défilement vers le haut